Heru

About:

Heru develops patented autonomous AI-powered vision diagnostics and augmentation software for use on commercially available AR/VR devices.

Website: https://www.seeheru.com/

Top Investors: Open Opportunity Fund, Krillion Ventures, D1 Capital Partners, Fred Moll, M.D, Maurice Ferre, M.D.

Description:

Heru Inc. (www.SeeHeru.com) has developed patented autonomous AI-powered vision diagnostics and augmentation software for use on commercially available AR/VR devices. This technology exceeds traditional standards of care in clinical equivalence, usability, cost, size, and portability. Heru is the only cross-platform solution that can autonomously diagnose vision defects and customize individual vision augmentation based on the user’s unique vision defects. Heru originated as a spinout from Bascom Palmer Eye Institute. In December 2020, Heru announced FDA registration and a seed round led by Fred Drasner, Maurice R. Ferre, M.D., Fred H. Moll, M.D., and a consortium of investors with extensive experience developing, launching, and scaling cutting-edge medical technologies.